|
1
|
Chaiworapongsa T, Chaemsaithong P, Yeo L
and Romero R: Pre-eclampsia part 1: Current understanding of its
pathophysiology. Nat Rev Nephrol. 10:466–480. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Osanai T, Magota K, Tanaka M, Shimada M,
Murakami R, Sasaki S, Tomita H, Maeda N and Okumura K:
Intracellular signaling for vasoconstrictor coupling factor 6:
Novel function of beta-subunit of ATP synthase as receptor.
Hypertension. 46:1140–1146. 2005.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Goldman-Wohl DS and Yagel S: Examination
of distinct fetal and maternal molecular pathways suggests a
mechanism for the development of preeclampsia. J Reprod Immunol.
76:54–60. 2007.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rattila S, Dunk CEE, Im M, Grichenko O,
Zhou Y, Yanez-Mo M, Blois SM, Yamada KM, Erez O, Gomez-Lopez N, et
al: Interaction of pregnancy-specific glycoprotein 1 with integrin
Α5β1 is a modulator of extravillous trophoblast functions. Cells.
8(1369)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Osanai T, Magota K and Okumura K: Coupling
factor 6 as a novel vasoactive and proatherogenic peptide in
vascular endothelial cells. Naunyn Schmiedebergs Arch Pharmacol.
380:205–214. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wang JR, Zuo H, Han XY and Yin G: Study on
changes of coupling factor 6 in pregnancy induced hypertension.
Maternal Child Health Care China. 20:2659–2660. 2005.(In
Chinese).
|
|
7
|
Zhu H, Chen L, Zhou W, Huang Z, Hu J, Dai
S, Wang X, Huang X and He C: Over-expression of the ATP5J gene
correlates with cell migration and 5-fluorouracil sensitivity in
colorectal cancer. PLoS One. 8(e76846)2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang Z, Zhang L, Yang X, Li Y and Duan Z:
Construction and validation of a placental tissue microarray from
specimens of well-documented preeclampsia patients. Placenta.
34:187–192. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
ACOG Committee on Practice
Bulletins-Obstetrics. ACOG practice bulletin. Diagnosis and
management of preeclampsia and eclampsia. Number 33, January 2002.
Obstet Gynecol. 99:159–167. 2002.PubMed/NCBI
|
|
10
|
Osanai T, Tanaka M, Kamada T, Nakano T,
Takahashi K, Okada S, Sirato K, Magota K, Kodama S and Okumura K:
Mitochondrial coupling factor 6 as a potent endogenous
vasoconstrictor. J Clin Invest. 108:1023–1030. 2001.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Tanaka M, Osanai T, Murakami R, Sasaki S,
Tomita H, Maeda N, Satoh K, Magota K and Okumura K: Effect of
vasoconstrictor coupling factor 6 on gene expression profile in
human vascular endothelial cells: Enhanced release of asymmetric
dimethylarginine. J Hypertens. 24:489–497. 2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Moser TL, Stack MS, Asplin I, Enghild JJ,
Hojrup P, Everitt L, Hubchak S, Schnaper HW and Pizzo SV:
Angiostatin binds ATP synthase on the surface of human endothelial
cells. Proc Natl Acad Sci USA. 96:2811–2816. 1999.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Cui N, Hu M and Khalil RA: Biochemical and
biological attributes of matrix metalloproteinases. Prog Mol Biol
Transl Sci. 147:1–73. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhang L, Li Y, Yang X and Zhang Z:
Detection of phosphorylated signal transducer and activator of
transcription 3 in extravillous trophoblast cells of preeclampsia
by placental tissue microarray. Chin J Perinatal Med. 16:479–484.
2013.
|
|
16
|
Bilban M, Tauber S, Haslinger P,
Pollheimer J, Saleh L, Pehamberger H, Wagner O and Knöfler M:
Trophoblast invasion: Assessment of cellular models using gene
expression signatures. Placenta. 31:989–996. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yuan Y, Hilliard G, Ferguson T and
Millhorn DE: Cobalt inhibits the interaction between
hypoxia-inducible factor-alpha and von Hippel-Lindau protein by
direct binding to hypoxia-inducible factor-alpha. J Biol Chem.
278:15911–15916. 2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sangawa H, Himeda T, Shibata H and Higuti
T: Gene expression of subunit c(P1), subunit c(P2), and oligomycin
sensitivity-conferring protein may play a key role in biogenesis of
H+-ATP synthase in various rat tissues. J Biol Chem.
272:6034–6037. 1997.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Osanai T, Kamada T, Fujiwara N, Katoh T,
Takahashi K, Kimura M, Satoh K, Magota K, Kodama S, Tanaka T and
Okumura K: A novel inhibitory effect on prostacyclin synthesis of
coupling factor 6 extracted from the heart of spontaneously
hypertensive rats. J Biol Chem. 273:31778–31783. 1998.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Fingleton B: Matrix metalloproteinases as
regulators of inflammatory processes. Biochim Biophys Acta Mol Cell
Res. 1864:2036–2042. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Staun-Ram E, Goldman S, Gabarin D and
Shalev E: Expression and importance of matrix metalloproteinase 2
and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod Biol
Endocrinol. 2(59)2004.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Schafer-Somi S, Ali Aksoy O, Patzl M,
Findik M, Erünal-Maral N, Beceriklisoy HB, Polat B and Aslan S: The
activity of matrix metalloproteinase-2 and -9 in serum of pregnant
and non-pregnant bitches. Reprod Domest Anim. 40:46–50. 2005.
|
|
23
|
Knowles AF, Guillory RJ and Racker E:
Partial resolution of the enzymes catalyzing oxidative
phosphorylation. XXIV. A factor required for the binding of
mitochondrial adenosine triphosphatase to the inner mitochondrial
membrane. J Biol Chem. 246:2672–2679. 1971.PubMed/NCBI
|
|
24
|
Tomita H, Osanai T, Toki T, Sasaki S,
Maeda N, Murakami R, Magota K, Yasujima M and Okumura K:
Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit
shear-induced coupling factor 6 release in endothelial cells.
Cardiovasc Res. 67:134–141. 2005.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sasaki S, Osanai T, Tomita H, Matsunaga T,
Magota K and Okumura K: Tumor necrosis factor alpha as an
endogenous stimulator for circulating coupling factor 6. Cardiovasc
Res. 62:578–586. 2004.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Li X, Xing S, Zhang L, Xing Q, Yan S, Dai
H, You S, Pang Y and Tang C: High glucose promotes the release and
expression of novel vasoactive peptide, coupling factor 6, in human
umbilical vein endothelial cells. Peptides. 28:683–690.
2007.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kumagai A, Osanai T, Katoh C, Tanaka M,
Tomita H, Morimoto T, Murakami R, Magota K and Okumura K: Coupling
factor 6 downregulates platelet endothelial cell adhesion
molecule-1 via c-Src activation and acts as a proatherogenic
molecule. Atherosclerosis. 200:45–50. 2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tzima E, Irani-Tehrani M, Kiosses WB,
Dejana E, Schultz DA, Engelhardt B, Cao G, DeLisser H and Schwartz
MA: A mechanosensory complex that mediates the endothelial cell
response to fluid shear stress. Nature. 437:426–431.
2005.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Echizen T, Osanai T, Ashitate T, Yokoyama
H, Shibutani S, Tanaka M, Tomita H, Magota K and Okumura K:
Upregulation of soluble vascular endothelial growth factor receptor
type 1 by endogenous prostacyclin inhibitor coupling factor 6 in
vascular endothelial cells: A role of acidosis-induced c-Src
activation. Hypertens Res. 32:182–187. 2009.PubMed/NCBI View Article : Google Scholar
|
